|
KMID : 0043319910140030242
|
|
Archives of Pharmacal Research
1991 Volume.14 No. 3 p.242 ~ p.248
|
|
|
Antihypertensive and Cardiovascular Effects of the New Calcium Antagonist YM334
|
|
Lee JW
Han BH/Lee JW/Seok JH/Kim SC/Hong YH/Suh JJ/Hong SU
|
|
|
Abstract
|
|
|
|
Antihypertensive effect of YH334 was examined in various experimental hypertension rat models and the systemic and regional hemodynamic profiles of the compound were investigated in conscious spontaneously hypertensive rats (SHR). The antihypertensive potency of YH334 is found to be more than 10 times stronger than that of nitrendipine in the all hypertensive models. The effective doses to lower the initial blood pressure by 20% (EDC20) of YH334 were 1.4mg/kg in normotensive rats (NR), 0.7mg/kg in SHP, 0.1mg/kg in DOCA salt hypertensive rats (DHR) and 0.4 mg/kg in renal hypertensive rats (RHR), and the ED20 values of nitrendipine were 15.8mg/kg in NR, 7.1mg/kg in SHR, 1.7mg/kg in DHR and 4.8mg/kg in RHR. The primary hemodynamic effect of YH334 was characterized by increasing CI and SVI and reducing TPRI of which hemodynamic profile is similar to that of nitrendipine. Both compounds seem to produce potent antihypertensive effects by lowering peripheral resistance in the skeletal muscles. In the organ bath study using isolated rabbit aorta, YH334 was found to be a potent voltage dependent calcium channel blocker without significant inhibitory effect on the receptor operated calcium channels like the most of other dihydropyridine type calcium antagonists. Furthermore, YH334 showed acute diuretic and natriuretic effects in conscious SHR, which may render the unnecessary restriction of sodium in the diet of those patients on long term hypertension therapy. This effect would provide an additional benefit to its potent antihypertensive activity.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|